Target intelligence / Profile preview

3'-5' RNA helicase YTHDC2 (YTHDC2)

Target
YTHDC2
Molecular classification
RNA helicase, RNA-binding protein, m6A reader protein, Enzyme
01

Overview

3'-5' RNA helicase YTHDC2 is a large, multi-domain RNA helicase that binds RNA through its YTH domain, specifically recognizing N6-methyladenosine (m6A) modifications, and through additional RNA-binding domains including an R3H domain and ankyrin repeats[3][4][6]. YTHDC2 is unique among YTH family proteins in containing a functional helicase module and plays a key role in promoting the mitotic-to-meiotic switch and progression through meiotic prophase during gametogenesis in both male and female germ lines[1][2][3][4]. It enhances the translation efficiency of its direct RNA targets and decreases their mRNA abundance, acting partially via interaction with the RNA degradation machinery such as the exonuclease XRN1 and helicases UPF1 and MOV10[1][6]. Loss of YTHDC2 function causes infertility in mammals due to failure of germ cells to progress past the zygotene stage of meiosis[1][2]. Although initially identified as an m6A reader, recent studies show it also binds other U-rich or UG-rich RNA motifs, and its meiotic regulatory function depends critically on its helicase activity[2][3]. There are currently no drugs specifically targeting this protein, but given its role in RNA metabolism and gametogenesis, it is emerging as a potential target for reproductive and cancer-related research[1][3][4][6].

Other names
YTH N6-methyladenosine RNA binding protein C2Probable ATP-dependent RNA helicase YTHDC2CAHLhYTHDC2FLJ2194FLJ10053DKFZp564A186YTH domain-containing protein 2CsA-associated helicase-like proteinYTH domain containing 2
02

Mechanism of action

Not established for drugs; for biology: Recognition and binding of m6A-modified RNA and helicase-dependent regulation of RNA metabolism[1][2][3][6].

03

Biological functions

Regulation of translation efficiencyRegulation of mRNA stability/decaym6A-modified RNA recognitionPromotion of mitosis-to-meiosis transition in germ cellsControl of gametogenesis
04

Disease associations

Infertility (failure of meiotic progression, germ cell arrest)Cancer (emerging evidence suggests a role, but still under study)
05

Safety considerations

Loss causes sterility due to meiotic arrest in mammals[1][2]No therapeutic targeting in clinical use; thus, no established drug-related safety concerns
06

Biomarkers

Germ cell development (YTHDC2 expression essential for progression before pachytene in meiosis)[1][2][4]

Beyond the preview

Go deeper on 3'-5' RNA helicase YTHDC2 (YTHDC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3'-5' RNA helicase YTHDC2 (YTHDC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call